Welcome to the “news” section of our website, where you'll find all the latest publications on our advances in research (Alzheimer's, Parkinson's, Charcot's disease, etc.), our upcoming events, etc.
Sometimes, in healthy tissues, mutated cells are seen that may or may not become malignant tumours. This phenomenon has already been described in the endometrium, oesophagus and epidermis. At Paris Brain Institute, Matthieu Peyre and his colleagues...
What if Alzheimer’s disease left its mark on the embryo? Khadijeh Shabani and her colleagues from the “Brain Development” team led by Bassem Hassan (Inserm) at Paris Brain Institute show that the amyloid precursor protein (APP) has a specific...
The diagnosis of atypical forms of Alzheimer's disease is still sometimes difficult. Researchers from Paris Brain Institute have developed an automated algorithm to correlate the specificities of brain lesions with the symptoms associated with these...
Although Alzheimer's disease is not inherited in 95% of cases, nearly 75 genetic susceptibility factors - that is, factors that increase the risk to develop the disease - or protective factors - that decrease the probability to be affected - have...
Although Alzheimer's disease is not hereditary in 99% of cases, genetic factors can increase the risk of developing it. The "Alzheimer's disease, prion diseases" team, co-directed by Marie-Claude Potier (CNRS) at the Paris Brain Institute, has...
What risk factors are associated with Alzheimer's up to 15 years before the onset of the first symptoms? This is a vital question for specialists of this neurodegenerative disease – which develops over many years before becoming clinically visible –...
New study conducted by Irini Kessissoglou in the “Brain development” team headed by Bassem Hassan at Paris Brain Institute reveals new functions for the Amyloid Precursor Protein (APP) homologue in drosophila. Results are published in PLOS Biology.
Early biomarkers are needed to identify individuals at high risk of preclinical Alzheimer's disease and to better understand the pathophysiological processes of disease progression. Preclinical Alzheimer's disease EEG changes would be non-invasive...
Alzheimer’s disease represents one of the largest remaining unsolved threats to our health. This disease in common with other neurological disorders has been elusive because it is hard to diagnose. Our current ability to diagnose Alzheimer’s disease...
A recent study directed by Professor Harald Hampel, researcher at the Institut du Cerveau - ICM, highlights the predictive potential for Alzheimer’s disease of a serological biomarker.
A major international conceptual diagnostic criteria and conceptual breakthrough program has been successfully launched and published, led by the UPMC and Institut du Cerveau - ICM researchers Professor Bruno Dubois and Professor Harald Hampel (AXA –...
